Assignee
FERRING BV
NL·156 granted patents·86 pending applications·1,955 citations·filing 1985–2025
Top patents by PatentIndex Score
242 records- 0196US11291708B2Human-derived recombinant FSH for controlled ovarian stimulationFERRING BV·Filed 2020·Granted Apr 5, 2022·5 cites·8 claims
- 0295US5939560AInhibitors of DP-mediated processes, compositions and therapeutic methods thereofFERRING BV·Filed 1994·Granted Aug 17, 1999·253 cites·8 claims
- 0394US11260102B2Manufacture of DegarelixFERRING BV·Filed 2020·Granted Mar 1, 2022·4 cites·16 claims
- 0494US10172906B2Manufacture of DegarelixFERRING BV·Filed 2017·Granted Jan 8, 2019·11 cites·14 claims
- 0593US11826397B2Method of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2022·Granted Nov 28, 2023·2 cites·11 claims
- 0693US6201132B1Inhibitors of DP-mediated processes, compositions, and therapeutic methods thereofFERRING BV·Filed 1999·Granted Mar 13, 2001·149 cites·4 claims
- 0792US10973870B2Methods of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2020·Granted Apr 13, 2021·6 cites·15 claims
- 0892US10765721B2Manufacture of DegarelixFERRING BV·Filed 2018·Granted Sep 8, 2020·6 cites·19 claims
- 0992US9592266B2Manufacture of degarelixFERRING BV·Filed 2013·Granted Mar 14, 2017·11 cites·14 claims
- 1092US8022106B2Tranexamic acid formulationsFERRING BV·Filed 2009·Granted Sep 20, 2011·12 cites·57 claims
- 1192US2025296967A1Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesisFERRING BV·Filed 2024·Application pending·0 cites
- 1291US11292824B2Pharmaceutical preparation comprising recombinant hCGFERRING BV·Filed 2019·Granted Apr 5, 2022·3 cites·6 claims
- 1391US9579359B2Method of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2013·Granted Feb 28, 2017·14 cites·13 claims
- 1490US9670258B2Positive modulator of bone morphogenic protein-2FERRING BV·Filed 2016·Granted Jun 6, 2017·6 cites·4 claims
- 1590US7947739B2Tranexamic acid formulationsFERRING BV·Filed 2010·Granted May 24, 2011·14 cites·19 claims
- 1690US7947654B2Pharmaceutical formulationsFERRING BV·Filed 2009·Granted May 24, 2011·9 cites·9 claims
- 1790US7816489B2Methods for making intermediates and oxytocin analoguesFERRING BV·Filed 2007·Granted Oct 19, 2010·10 cites·9 claims
- 1890US7560429B2Orodispersible dosage forms of desmopressin acetateFERRING BV·Filed 2003·Granted Jul 14, 2009·24 cites·19 claims
- 1990US6521644B1Compositions for promoting growthFERRING BV·Filed 2000·Granted Feb 18, 2003·62 cites·16 claims
- 2089US11766468B2Method of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2020·Granted Sep 26, 2023·2 cites·11 claims
- 2189US10695398B2Method of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2016·Granted Jun 30, 2020·7 cites·8 claims
- 2289US10624953B2Human-derived recombinant FSH for controlled ovarian stimulationFERRING BV·Filed 2017·Granted Apr 21, 2020·6 cites·15 claims
- 2389US10526390B2Pharmaceutical preparation comprising recombinant HcGFERRING BV·Filed 2017·Granted Jan 7, 2020·6 cites·12 claims
- 2489US9579305B2Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologiesFERRING BV·Filed 2015·Granted Feb 28, 2017·7 cites·22 claims
- 2589US5990273ASynthesis of cyclic peptidesFERRING BV·Filed 1997·Granted Nov 23, 1999·74 cites·15 claims
- 2688US11020448B2Methods comprising desmopressinFERRING BV·Filed 2018·Granted Jun 1, 2021·4 cites·13 claims
- 2788US10617644B2Composition for the treatment of fistulaFERRING BV·Filed 2017·Granted Apr 14, 2020·3 cites·17 claims
- 2888US10588926B2Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosisFERRING BV·Filed 2016·Granted Mar 17, 2020·2 cites·20 claims
- 2988US9096335B2Fast dissolving pharmaceutical compositionFERRING BV·Filed 2013·Granted Aug 4, 2015·12 cites·23 claims
- 3088US6911467B2Antidiabetic agentsFERRING BV·Filed 2000·Granted Jun 28, 2005·19 cites·23 claims
- 3188US2025134948A1METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONISTFERRING BV·Filed 2024·Application pending·0 cites
- 3287US11673918B2Method of manufacturing a pharmaceutical compositionFERRING BV·Filed 2021·Granted Jun 13, 2023·2 cites·13 claims
- 3387US7094545B2Pharmaceutical composition as solid dosage form and method for manufacturing thereofFERRING BV·Filed 2003·Granted Aug 22, 2006·29 cites·15 claims
- 3487US7074781B2Condensed azepines as vasopressin agonistsFERRING BV·Filed 2001·Granted Jul 11, 2006·30 cites·16 claims
- 3586US12514898B2Methods of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2024·Granted Jan 6, 2026·0 cites·7 claims
- 3686US9682101B2Composition for the treatment of diseaseFERRING BV·Filed 2014·Granted Jun 20, 2017·7 cites·23 claims
- 3786US7091314B2Intermediates and methods for making heptapeptide oxytocin analoguesFERRING BV·Filed 2004·Granted Aug 15, 2006·11 cites·15 claims
- 3886US7022340B2Pharmaceutical composition as solid dosage form and method for manufacturing thereofFERRING BV·Filed 2003·Granted Apr 4, 2006·30 cites·55 claims
- 3986US6214798B1GnRH antagonists being modified in positions 5 and 6FERRING BV·Filed 1998·Granted Apr 10, 2001·62 cites·20 claims
- 4086US5965701AKappa receptor opioid peptidesFERRING BV·Filed 1997·Granted Oct 12, 1999·84 cites·21 claims
- 4186US5925730AGnRH antagonistsFERRING BV·Filed 1997·Granted Jul 20, 1999·60 cites·21 claims
- 4286US5725872AComposition for foams, notably rectal foams, and foams thus obtainedFERRING BV·Filed 1996·Granted Mar 10, 1998·115 cites·64 claims
- 4385US11712422B2Pharmaceutical compositions comprising activated carbonFERRING BV·Filed 2020·Granted Aug 1, 2023·1 cites·18 claims
- 4485US10174088B2Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesisFERRING BV·Filed 2017·Granted Jan 8, 2019·2 cites·8 claims
- 4585US9676835B2Pharmaceutical preparation comprising recombinant HcGFERRING BV·Filed 2014·Granted Jun 13, 2017·6 cites·20 claims
- 4685US7964562B2Unitary combinations of FSH and hCGFERRING BV·Filed 2007·Granted Jun 21, 2011·13 cites·7 claims
- 4784US10307459B2Pharmaceutical formulations of desmopressinFERRING BV·Filed 2018·Granted Jun 4, 2019·2 cites·15 claims
- 4884US10246499B2Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesisFERRING BV·Filed 2014·Granted Apr 2, 2019·3 cites·16 claims
- 4984US10137167B2Methods comprising desmopressinFERRING BV·Filed 2013·Granted Nov 27, 2018·4 cites·13 claims
- 5084US7304181B2Methods for making intermediates and oxytocin analoguesFERRING BV·Filed 2006·Granted Dec 4, 2007·4 cites·20 claims
Showing the top 50 of 242 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when FERRING BV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →